Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double-strand break repair protein MRE11 is a highly conserved nuclear enzyme with both exonuclease and endonuclease activity, encoded by the MRE11A gene in humans. It functions primarily in the detection and repair of DNA double-strand breaks, crucial for maintaining genomic stability. MRE11 forms the MRN complex with Rad50 and NBS1, facilitating both homologous recombination and nonhomologous DNA end joining, and has important roles in telomere maintenance. Deficiency or mutation of MRE11 impairs DNA repair, leading to increased susceptibility to cancer and genomic disorders.
If targeted, drugs would likely inhibit its nuclease activity, impairing the repair of DNA double-strand breaks and sensitizing cells to DNA-damaging agents (e.g., radiotherapy, chemotherapy)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double-strand break repair protein MRE11 (MRE11).